Biotechnology Incentives Leadership Operations 
Harvard Business Review
MAY 1, 2014
I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. To save the 20-year-old company, I had to get it operating like a start-up. My senior executives and I made our values the language of leadership. This must come from the top.
Harvard Business Review
JUNE 16, 2016
“But here, we can operate within the time frame of the next coffee break.” ” That’s really essential, because the different players often have widely divergent incentives. Firms have also invested additional money to build facilities near the hubs to better integrate their operations with them.
Expert insights. Personalized for you.
8 
Let's personalize your content